Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
June 3rd, 2018
9.8K views
The aim of this study was to improve the co-registration for image fusion (IF) of pre-interventional CT data with real-time x-ray (XR) fluoroscopy during transfemoral transcatheter aortic valve implantation (TAVI).
Overview
This study focuses on enhancing the co-registration for image fusion of pre-interventional CT data with real-time x-ray fluoroscopy during transfemoral transcatheter aortic valve implantation (TAVI). The method aims to improve the anatomical guidance available during complex interventions, ultimately increasing the efficacy and safety of procedures.
Key Study Components
Area of Science
- Interventional cardiology
- Image-based guidance
- Transcatheter aortic valve implantation
Background
- Real-time x-ray fluoroscopy provides limited anatomical information.
- Increasing complexity of TAVR procedures necessitates improved imaging solutions.
- Image fusion techniques can enhance procedural guidance.
- Manual segmentation of anatomical structures is crucial for accurate overlays.
Purpose of Study
- To improve co-registration techniques for better image fusion.
- To facilitate accurate navigation during complex interventional procedures.
- To enhance the safety and efficacy of TAVI procedures.
Methods Used
- Segmentation of CT images for aorta and left ventricle.
- Manual alignment of anatomical models with x-ray projections.
- Use of interaction tools for real-time adjustments during procedures.
- Application of reference markers for precise anatomical localization.
Main Results
- Improved accuracy in overlaying anatomical structures during interventions.
- Successful application of the method in various transcatheter procedures.
- Demonstrated effectiveness in guiding complex anatomical placements.
- Reduction in technical difficulties associated with anatomical misalignment.
Conclusions
- The protocol enhances the guidance of interventional procedures.
- Manual segmentation can be efficiently completed in a short time.
- Increased number of projections improves overlay accuracy.
Frequently Asked Questions
What is the main focus of this study?
The study aims to improve co-registration for image fusion during TAVI procedures.
How does this method enhance procedural safety?
By providing better anatomical guidance, it reduces the risk of complications during interventions.
What are the key techniques used in this study?
Segmentation of CT images and manual alignment with x-ray projections are key techniques.
Can this method be applied to other procedures?
Yes, the protocol is applicable to a variety of transcatheter interventions.
How long does manual segmentation take?
It can typically be completed in 20-30 minutes, depending on CT image quality.
What challenges are addressed by this study?
The study addresses challenges related to anatomical misalignment and limited imaging information.
Executive Industry Relevance
Accurate image fusion between pre-procedural CT angiography and intra-operative fluoroscopy is critical for guiding complex transcatheter interventions, where limited anatomical visibility from x-ray alone increases procedural risk. This method enhances targeting precision and device placement by leveraging routinely acquired arteriograms, reducing the need for additional contrast or radiation exposure. Improved co-registration supports safer navigation in structurally challenging anatomies, directly impacting procedural success rates and patient safety in structural heart interventions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables functional validation of vascular access and device deployment pathways in clinically relevant anatomical models.
- Operational Value: Reduces reliance on supplemental imaging steps, streamlining preclinical workflow efficiency.
Screening & Assay Development
- Scientific Value: Provides standardized anatomical reference frames for consistent device positioning across test iterations.
- Operational Value: Supports reproducible overlay alignment, minimizing variability in interventional device evaluation.
Translational & Preclinical Research
- Scientific Value: Bridges ex-vivo anatomical modeling with in-vivo-like procedural guidance, enhancing predictive validity.
- Operational Value: Facilitates iterative device optimization using real-time anatomical feedback without repeated contrast administration.
Pipeline & Workflow Integration
The method integrates into the transcatheter device development continuum by improving anatomical fidelity during functional testing, from early vascular access simulation to final deployment validation.
- Discovery Biology: Supports hypothesis testing of device-tissue interactions under realistic anatomical constraints.
- Screening: Enables quantitative assessment of device positioning accuracy across anatomical variants.
- Analytics: Generates spatial overlay metrics that inform device design iterations and delivery system refinement.
- Translational Research: Aligns with preclinical continuity by simulating clinical guidance workflows in controlled environments.
- Enterprise Reuse: Establishes a reusable image fusion platform applicable across multiple structural heart device programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in device-tissue alignment, reducing mechanistic ambiguity in preclinical studies.
- Operational Value: Enhances reproducibility and standardization of guidance protocols across laboratories and sites.
- Strategic Value: Improves go/no-go decision-making by minimizing false-negative results due to poor anatomical visualization.
- Portfolio Impact: De-risks advancement decisions by validating device performance under clinically representative navigation conditions.
Implementation Considerations
- Expertise in medical image segmentation and 3D model registration is required.
- Access to compatible image fusion software with manual adjustment tools is necessary.
- Standardization of reference marker placement across operators ensures consistent overlay accuracy.
- Adaptation to different CTA protocols and vascular anatomies may require protocol adjustments.
- Manual correction steps introduce operator dependency, necessitating training for reliable use.
Biopharma FAQs
Why does co-registration accuracy matter for target validation in transcatheter device studies?
Accurate co-registration ensures that anatomical models align precisely with intra-procedural imaging, enabling reliable assessment of device-tissue interactions. Misalignment can lead to false conclusions about delivery success or deployment position. This method improves validation confidence by using routinely acquired arteriograms for real-time refinement.
How does isolating the iliofemoral vasculature as an independent variable improve device navigation studies?
Focusing on the iliofemoral arteries allows for targeted co-registration using standard access-site angiograms, minimizing variables from unrelated anatomical motion. This isolation enhances reproducibility in preclinical guidance simulations. It supports consistent modeling of the femoral access pathway, a critical early step in transcatheter procedures.
What quantitative outputs from manual segmentation and overlay alignment enable comparative device evaluation?
Spatial accuracy of the anatomical overlay, measured as deviation from reference markers, provides a quantifiable metric for device positioning fidelity. Consistent manual segmentation of vascular structures allows for standardized baseline models across test groups. These outputs help teams compare delivery system performance under matched anatomical conditions.
Why are replication requirements important for cross-functional collaboration in image-guided device development?
Replication ensures that co-registration results are not dependent on a single operator’s technique or image quality, supporting multi-site validity. Standardized segmentation and alignment protocols allow imaging, preclinical, and engineering teams to compare data reliably. This reduces variability in interpreting device navigability and deployment success.
What statistical analysis capabilities are required before implementing this co-registration method in preclinical workflows?
Teams must be able to quantify overlay error distributions across multiple runs and anatomical variants to assess method robustness. Statistical comparison of targeting accuracy with and without the method supports objective evaluation of its impact. These analyses help determine whether the method significantly reduces guidance-related variability in device studies.
